pindolol has been researched along with ADDH in 2 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Excerpt | Relevance | Reference |
---|---|---|
"Pindolol treatment was associated with a higher incidence of paraesthesias and with more intense nightmares and hallucinations than MPH or placebo treatment." | 2.68 | Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder. Clinical efficacy and side-effects. ( Buitelaar, JK; Kuiper, M; Swaab-Barneveld, H; van der Gaag, RJ, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Riley, TB | 1 |
Overton, PG | 1 |
Buitelaar, JK | 1 |
van der Gaag, RJ | 1 |
Swaab-Barneveld, H | 1 |
Kuiper, M | 1 |
1 trial available for pindolol and ADDH
Article | Year |
---|---|
Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder. Clinical efficacy and side-effects.
Topics: Adolescent; Adrenergic beta-Antagonists; Attention Deficit Disorder with Hyperactivity; Central Nerv | 1996 |
1 other study available for pindolol and ADDH
Article | Year |
---|---|
Enhancing the efficacy of 5-HT uptake inhibitors in the treatment of attention deficit hyperactivity disorder.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Clinical Trials as Topic; Dioxanes; Drug Adm | 2019 |